aiiaoaiiao.it/pdf_atti_congressuali/2807_1. epidemiologia, patogenesi, targeting zero e...bart 1-2;...
TRANSCRIPT
![Page 1: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/1.jpg)
![Page 2: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/2.jpg)
![Page 3: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/3.jpg)
![Page 4: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/4.jpg)
Equa! sized I
Enhanced exlension --~.eg sirDnnih
Re-verse taperenl1ances streng1h
f6G~
Negative pre-ssure cpens valve- -nward. permitiing blood asDira'
_ Posifive pressure opens valVeOUMard. allolNing infusion
neutral pressare, valve rem.:urcIo5ed, reducino risk cf air emb
![Page 5: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/5.jpg)
\ __"'
\ \1I ----'.~~l
L
![Page 6: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/6.jpg)
![Page 7: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/7.jpg)
![Page 8: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/8.jpg)
#4 Thorax 1X105
\Axilila 5X 106
Head/Scalp 1X1 06
#1
#3 Abdol;
5X104
Ryder, AV:" ~011,SHIEA 2n11
![Page 9: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/9.jpg)
![Page 10: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/10.jpg)
![Page 11: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/11.jpg)
![Page 12: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/12.jpg)
![Page 13: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/13.jpg)
![Page 14: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/14.jpg)
![Page 15: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/15.jpg)
![Page 16: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/16.jpg)
![Page 17: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/17.jpg)
![Page 18: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/18.jpg)
![Page 19: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/19.jpg)
![Page 20: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/20.jpg)
![Page 21: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/21.jpg)
![Page 22: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/22.jpg)
![Page 23: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/23.jpg)
![Page 24: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/24.jpg)
![Page 25: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/25.jpg)
![Page 26: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/26.jpg)
![Page 27: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/27.jpg)
![Page 28: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/28.jpg)
![Page 29: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/29.jpg)
![Page 30: AIIAOaiiao.it/pdf_atti_congressuali/2807_1. Epidemiologia, Patogenesi, Targeting Zero e...bart 1-2; Vascular Access Device Market by Segment, Europe, 2007 Chart 1-4: CAGR for the Vascular](https://reader033.vdocuments.site/reader033/viewer/2022052019/60333f7ff1f083376d64c465/html5/thumbnails/30.jpg)